| Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 366 (9503), 2087-2106, 2005 | 6323 | 2005 |
| Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 A Goldhirsch, WC Wood, AS Coates, RD Gelber, B Thürlimann, HJ Senn Annals of oncology 22 (8), 1736-1747, 2011 | 5013 | 2011 |
| Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ... Annals of oncology 24 (9), 2206-2223, 2013 | 4554 | 2013 |
| Tamoxifen for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 351 (9114), 1451-1467, 1998 | 4174 | 1998 |
| Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ... Annals of oncology 26 (8), 1533-1546, 2015 | 2337 | 2015 |
| Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 379 (9814), 432-444, 2012 | 2291 | 2012 |
| Polychemotherapy for early breast cancer: an overview of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 352 (9132), 930-942, 1998 | 2160 | 1998 |
| Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 A Goldhirsch, JN Ingle, RD Gelber, AS Coates, B Thürlimann, HJ Senn Annals of oncology 20 (8), 1319-1329, 2009 | 1979 | 2009 |
| Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women … DLW Kwong, P McGale, C Taylor, C Correa, D Cutter, F Duane, M Ewertz, ... The Lancet, 2014 | 1972 | 2014 |
| A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer Breast International Group (BIG) 1-98 Collaborative Group New England Journal of Medicine 353 (26), 2747-2757, 2005 | 1963 | 2005 |
| Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma MR Middleton, JJ Grob, N Aaronson, G Fierlbeck, W Tilgen, S Seiter, ... Journal of Clinical Oncology 18 (1), 158-158, 2000 | 1679 | 2000 |
| Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 A Goldhirsch, JH Glick, RD Gelber, AS Coates, B Thürlimann, HJ Senn, ... Annals of oncology 16 (10), 1569-1583, 2005 | 1603 | 2005 |
| Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (10001), 1341-1352, 2015 | 1375 | 2015 |
| Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 A Goldhirsch, WC Wood, RD Gelber, AS Coates, B Thürlimann, HJ Senn, ... Annals of oncology 18 (7), 1133-1144, 2007 | 1331 | 2007 |
| Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial V Galimberti, BF Cole, S Zurrida, G Viale, A Luini, P Veronesi, P Baratella, ... The lancet oncology 14 (4), 297-305, 2013 | 1321 | 2013 |
| On the receiving end—patient perception of the side-effects of cancer chemotherapy A Coates, S Abraham, SB Kaye, T Sowerbutts, C Frewin, RM Fox, ... European Journal of Cancer and Clinical Oncology 19 (2), 203-208, 1983 | 1219 | 1983 |
| Meeting highlights: international consensus panel on the treatment of primary breast cancer A Goldhirsch, JH Glick, RD Gelber, AS Coates, HJ Senn Journal of Clinical Oncology 19 (18), 3817-3827, 2001 | 1173* | 2001 |
| Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98 AS Coates, A Keshaviah, B Thürlimann, H Mouridsen, L Mauriac, ... Journal of clinical oncology 25 (5), 486-492, 2007 | 1155 | 2007 |
| Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial RC Coombes, LS Kilburn, CF Snowdon, R Paridaens, RE Coleman, ... The Lancet 369 (9561), 559-570, 2007 | 1106 | 2007 |
| Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen M Dowsett, J Cuzick, J Ingle, A Coates, J Forbes, J Bliss, M Buyse, ... Journal of Clinical Oncology 28 (3), 509-518, 2010 | 1068 | 2010 |
Richard GelberProfessor, Harvard Medical School, Harvard TH Chan School of Public Health, Dana-Farber Cancer Institute, Frontier Science Foundationایمیل تأیید شده در ds.dfci.harvard.edu
